Literature DB >> 26961090

Cannabis in Pain Treatment: Clinical and Research Considerations.

Seddon R Savage1, Alfonso Romero-Sandoval2, Michael Schatman3, Mark Wallace4, Gilbert Fanciullo5, Bill McCarberg4, Mark Ware6.   

Abstract

UNLABELLED: Cannabinoids show promise as therapeutic agents, particularly as analgesics, but their development and clinical use has been complicated by recognition of their botanical source, cannabis, as a substance of misuse. Although research into endogenous cannabinoid systems and potential cannabinoid pharmaceuticals is slowly increasing, there has been intense societal interest in making herbal (plant) cannabis available for medicinal use; 23 U.S. States and all Canadian provinces currently permit use in some clinical contexts. Whether or not individual professionals support the clinical use of herbal cannabis, all clinicians will encounter patients who elect to use it and therefore need to be prepared to advise them on cannabis-related clinical issues despite limited evidence to guide care. Expanded research on cannabis is needed to better determine the individual and public health effects of increasing use of herbal cannabis and to advance understanding of the pharmaceutical potential of cannabinoids as medications. This article reviews clinical, research, and policy issues related to herbal cannabis to support clinicians in thoughtfully advising and caring for patients who use cannabis, and it examines obstacles and opportunities to expand research on the health effects of herbal cannabis and cannabinoids. PERSPECTIVE: Herbal cannabis is increasingly available for clinical use in the United States despite continuing controversies over its efficacy and safety. This article explores important considerations in the use of plant Cannabis to better prepare clinicians to care for patients who use it, and identifies needed directions for research.
Copyright © 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabis; marijuana

Mesh:

Substances:

Year:  2016        PMID: 26961090     DOI: 10.1016/j.jpain.2016.02.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  28 in total

Review 1.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

2.  Development of an Algorithm to Identify Cannabis Urine Drug Test Results within a Multi-Site Electronic Health Record System.

Authors:  Benjamin J Morasco; Sarah E Shull; Melissa H Adams; Steven K Dobscha; Travis I Lovejoy
Journal:  J Med Syst       Date:  2018-07-24       Impact factor: 4.460

3.  High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.

Authors:  Kevin F Boehnke; J Ryan Scott; Evangelos Litinas; Suzanne Sisley; David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2019-09-24       Impact factor: 5.820

Review 4.  Medical cannabis for chronic pain: can it make a difference in pain management?

Authors:  Mari Kannan Maharajan; Yu Jing Yong; Hong Yang Yip; Sze Shee Woon; Kar Mon Yeap; Khai Yeng Yap; Shuen Chi Yip; Kai Xian Yap
Journal:  J Anesth       Date:  2019-09-18       Impact factor: 2.078

5.  Effects of cannabinoid administration for pain: A meta-analysis and meta-regression.

Authors:  Julio A Yanes; Zach E McKinnell; Meredith A Reid; Jessica N Busler; Jesse S Michel; Melissa M Pangelinan; Matthew T Sutherland; Jarred W Younger; Raul Gonzalez; Jennifer L Robinson
Journal:  Exp Clin Psychopharmacol       Date:  2019-05-23       Impact factor: 3.157

6.  A prospective observational study of problematic oral cannabinoid use.

Authors:  Mark A Ware; Marc O Martel; Roman Jovey; Mary E Lynch; Joel Singer
Journal:  Psychopharmacology (Berl)       Date:  2017-12-17       Impact factor: 4.530

7.  Medical marijuana research for chronic pain.

Authors:  Dermot P Maher; Steven P Cohen
Journal:  Lancet Psychiatry       Date:  2017-07       Impact factor: 27.083

Review 8.  Medical Cannabis for Older Patients.

Authors:  Amir Minerbi; Winfried Häuser; Mary-Ann Fitzcharles
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

9.  Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy.

Authors:  Shannon M Nugent; Bobbi Jo Yarborough; Ning X Smith; Steven K Dobscha; Richard A Deyo; Carla A Green; Benjamin J Morasco
Journal:  Gen Hosp Psychiatry       Date:  2017-11-08       Impact factor: 3.238

Review 10.  Medical Cannabis for Neuropathic Pain.

Authors:  Gemayel Lee; Brittany Grovey; Tim Furnish; Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.